Abstract
The alpha-thalassemia mental retardation X-linked (ATRX) syndrome protein is a chromatin remodeling protein that primarily promotes the deposit of H3.3 histone variants in the telomere area. ATRX mutations not only cause ATRX syndrome but also influence development and promote cancer. The primary molecular characteristics of ATRX, including its molecular structures and normal and malignant biological roles, are reviewed in this article. We discuss the role of ATRX in its interactions with the histone variant H3.3, chromatin remodeling, DNA damage response, replication stress, and cancers, particularly gliomas, neuroblastomas, and pancreatic neuroendocrine tumors. ATRX is implicated in several important cellular processes and serves a crucial function in regulating gene expression and genomic integrity throughout embryogenesis. However, the nature of its involvement in the growth and development of cancer remains unknown. As mechanistic and molecular investigations on ATRX disclose its essential functions in cancer, customized therapies targeting ATRX will become accessible.
Funding Information
  • National Natural Science Foundation of China (82172820, 81771332, 22ZR1466200, 22ZR1451200, PWZxq2022-10, PWYgy 2021-07)
  • Fundamental Research for the Central University, the Natural Science Foundation of Shanghai (82172820, 81771332, 22ZR1466200, 22ZR1451200, PWZxq2022-10, PWYgy 2021-07)
  • Key Disciplines Group Construction Project of Shanghai Pudong New Area Health Commission (82172820, 81771332, 22ZR1466200, 22ZR1451200, PWZxq2022-10, PWYgy 2021-07)
  • Medical Discipline Construction Project of Pudong Health Committee of Shanghai (82172820, 81771332, 22ZR1466200, 22ZR1451200, PWZxq2022-10, PWYgy 2021-07)

This publication has 155 references indexed in Scilit: